Ocular Therapeutix
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $13,459 | $10,634 | $17,082 | $15,425 |
Gross Profit | 11,515 | 9,372 | 15,852 | 13,864 |
EBITDA | -63,771 | -63,917 | -44,331 | -32,310 |
EBIT | -64,797 | -67,037 | -45,282 | -33,269 |
Net Income | -67,814 | -64,053 | -48,388 | -36,493 |
Net Change In Cash | 13,459 | 10,634 | 17,082 | 15,425 |
Free Cash Flow | -56,483 | -46,604 | -39,631 | -36,648 |
Cash | 391,134 | 349,681 | 392,102 | 427,220 |
Basic Shares | 172,594 | 169,397 | 168,019 | 166,993 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $63,723 | $58,443 | $51,494 | $43,522 |
Gross Profit | 58,097 | 53,162 | 46,954 | 39,116 |
EBITDA | -176,143 | -66,415 | -61,907 | -75,616 |
EBIT | -179,929 | -69,398 | -64,016 | -78,037 |
Net Income | -193,506 | -80,736 | -63,422 | -10,804 |
Net Change In Cash | 63,723 | 58,443 | 51,494 | 43,522 |
Cost of Revenue | -61,864 | -63,893 | ||
Free Cash Flow | -135,965 | -76,321 | -63,318 | -66,744 |
Cash | 392,102 | 195,807 | 102,300 | 164,164 |
Basic Shares | 158,265 | 85,596 | 76,875 | 82,162 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.39 |
2025-03-31 | -$0.37 |
2024-12-31 | -$0.29 |
